These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 28335700

  • 1. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
    Harris F, Tysome JR, Donnelly N, Durie-Gair J, Crundwell G, Tam YC, Knight RD, Vanat ZH, Folland N, Axon P.
    Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
    [Abstract] [Full Text] [Related]

  • 2. Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.
    Peng KA, Lorenz MB, Otto SR, Brackmann DE, Wilkinson EP.
    Laryngoscope; 2018 Sep; 128(9):2163-2169. PubMed ID: 29573425
    [Abstract] [Full Text] [Related]

  • 3. Auditory brainstem implants in NF2 patients: results and review of the literature.
    Sanna M, Di Lella F, Guida M, Merkus P.
    Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
    [Abstract] [Full Text] [Related]

  • 4. English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2.
    Tysome JR, Axon PR, Donnelly NP, Evans DG, Ferner RE, O'Connor AF, Freeman SR, Gleeson M, Halliday D, Harris F, Jiang D, Kerr R, King A, Knight RD, Lloyd SK, Macfarlane R, Mannion R, Mawman D, O'Driscoll M, Parry A, Ramsden J, Ramsden R, Rutherford SA, Saeed SR, Thomas N, Vanat ZH.
    Otol Neurotol; 2013 Dec; 34(9):1743-7. PubMed ID: 24136318
    [Abstract] [Full Text] [Related]

  • 5. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
    Carlson ML, Breen JT, Driscoll CL, Link MJ, Neff BA, Gifford RH, Beatty CW.
    Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
    [Abstract] [Full Text] [Related]

  • 6. Cochlear implantation after radiosurgery for vestibular schwannoma.
    Patel NS, Carlson ML, Link MJ, Neff BA, Van Gompel JJ, Driscoll CLW.
    J Neurosurg; 2021 Jul 01; 135(1):126-135. PubMed ID: 34250789
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
    North HJ, Mawman D, O'Driscoll M, Freeman SR, Rutherford SA, King AT, Hammerbeck-Ward C, Evans DG, Lloyd SK.
    Cochlear Implants Int; 2016 Jul 01; 17(4):172-177. PubMed ID: 27691934
    [Abstract] [Full Text] [Related]

  • 10. Auditory brainstem implants for neurofibromatosis type 2.
    Colletti L, Shannon R, Colletti V.
    Curr Opin Otolaryngol Head Neck Surg; 2012 Oct 01; 20(5):353-7. PubMed ID: 22886036
    [Abstract] [Full Text] [Related]

  • 11. Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis.
    Dornhoffer JR, Plitt AR, Lohse CM, Driscoll CLW, Neff BA, Saoji AA, Van Gompel JJ, Link MJ, Carlson ML.
    Otol Neurotol; 2024 Jan 01; 45(1):29-35. PubMed ID: 37875011
    [Abstract] [Full Text] [Related]

  • 12. Auditory outcomes in tumor vs. nontumor patients fitted with auditory brainstem implants.
    Colletti V.
    Adv Otorhinolaryngol; 2006 Jan 01; 64():167-185. PubMed ID: 16891842
    [Abstract] [Full Text] [Related]

  • 13. Hearing restoration in NF2 patients and patients with vestibular schwannoma in the only hearing ear: report of two cases.
    Ozdek A, Bayır O, Dönmez T, Ozışık P, Sahin M, Tulgar M, Tatar EÇ, Korkmaz MH.
    Am J Otolaryngol; 2014 Jan 01; 35(4):538-41. PubMed ID: 24746329
    [Abstract] [Full Text] [Related]

  • 14. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients.
    Grayeli AB, Kalamarides M, Bouccara D, Ambert-Dahan E, Sterkers O.
    Otol Neurotol; 2008 Dec 01; 29(8):1140-6. PubMed ID: 18849886
    [Abstract] [Full Text] [Related]

  • 15. Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2.
    Lloyd SK, Glynn FJ, Rutherford SA, King AT, Mawman DJ, O'Driscoll MP, Evans DG, Ramsden RT, Freeman SR.
    Otol Neurotol; 2014 Jan 01; 35(1):43-51. PubMed ID: 24335931
    [Abstract] [Full Text] [Related]

  • 16. Beneficial auditory and cognitive effects of auditory brainstem implantation in children.
    Colletti L.
    Acta Otolaryngol; 2007 Sep 01; 127(9):943-6. PubMed ID: 17712673
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.
    Roehm PC, Mallen-St Clair J, Jethanamest D, Golfinos JG, Shapiro W, Waltzman S, Roland JT.
    J Neurosurg; 2011 Oct 01; 115(4):827-34. PubMed ID: 21761973
    [Abstract] [Full Text] [Related]

  • 20. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR, Yeagle J, Driscoll CL, Blevins N, Francis H, Niparko JK.
    Otol Neurotol; 2006 Jun 01; 27(4):512-8. PubMed ID: 16791043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.